Predicting the public health impact of a malaria transmission-blocking vaccine
Malaria transmission-blocking vaccines are in development, but roll-out strategies have not been assessed. Here, the authors show that transmission-blocking activity is likely to be higher in the field than in laboratory conditions, and that school-aged children are an important group to target.
Guardado en:
Autores principales: | Joseph D. Challenger, Daniela Olivera Mesa, Dari F. Da, R. Serge Yerbanga, Thierry Lefèvre, Anna Cohuet, Thomas S. Churcher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41ceb2127e404427bfbc8cb9e56a16c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations
por: Anais Bompard, et al.
Publicado: (2017) -
Identification of Novel Malaria Transmission-Blocking Vaccine Candidates
por: Eizo Takashima, et al.
Publicado: (2021) -
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines
por: Darren B. Leneghan, et al.
Publicado: (2017) -
Non-genetic determinants of mosquito competence for malaria parasites.
por: Thierry Lefèvre, et al.
Publicado: (2013) -
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
por: Stephen W. Scally, et al.
Publicado: (2017)